Prof. Dr. Peter Lichter

Deputy Managing Director, NCT Heidelberg
Molecular Genetics

Phone: +49 6221 42-4619
Fax: +49 6221 42-4639

Since 1992, Professor Peter Lichter has been head of the Molecular Genetics Division at the German Cancer Research Center (DKFZ) and since 2015 he ist Deputy Managing Director of the NCT. He is member and chair of various international bodies and coordinator of several scientific networks in the fields of cancer genome analysis and personalized oncology.

He is the spokesperson for the Heidelberg Center for Personalized Oncology (DKFZ-HIPO) and editor in chief of the International Journal of Cancer. One primary focus of his scientific work is the characterization of the human genome/epigenome in cancer cells and the investigation of pathomechanisms for the formation and development of tumors. He has made important contributions to the development of new treatment strategies and the  determination of new prognostic and predictive biomarkers for cancer patients. He has published over 450 original articles in renowned journals.

Since 2015
Deputy Managing Director of the NCT

Since 2011

Speaker of the Heidelberger Center for Personalized Oncology (DKFZ-HIPO)

Since 2009
Editor-in-chief, International Journal of Cancer

Since 2009
Member of EACS (European Academy of Cancer Sciences)

Since 2008
Member of EMBO (European Molecular Biology Organization)

Since 2006
Member of Leopoldina

Member of "Wissenschaftsrat"

Sci. Progr. Committee of the Eur. Soc. of Human Genetics


Interim Director of the Management Board of the DKFZ

Since 2000
Full Professor at the Faculty of Medicine, University of Heidelberg

Habilitation and venia legendi in Molecular Human Genetics, Faculty of Medicine, University of Heidelberg

Since 1992
Head of Division Molecular Genetics, DKFZ

Head of project group “Organization of complex genomes”, DKFZ

"Deutsche Forschungsgemeinschaft" fellowship

EMBO long term fellowship

Postdoc in the laboratory of Prof. D.C. Ward, Dept. of Genetics, School of Medicine, Yale University, New Haven, USA

Graduation (Biology) and PhD degree University of Heidelberg

Johann-Georg-Zimmermann-Medal (2014/2015)

Jacob-Henle-Medal of the University medicine Göttingen


Award of the European Society of Human Genetics

Award of the Wilhelm Warner Foundation

Award of "Deutschen Krebshilfe" (German Cancer Aid)


"Deutscher Krebspreis" (German Cancer Award)

"Walther und Christine Richtzenhain" Award

Award of the (German) Society for Human Genetics

"Karl-Freudenberg" Award of the Academy of Sciences, Heidelberg

Jasmin Müller

Jasmin Müller

Phone: +49 6221 42-4619
Fax: +49 6221 42-4639

Zuckermann, M., et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun. Jun 11 (2015)

Hovestadt, V., et al. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. Nature 510, 537-41 (2014)

Tönjes, M., et al. BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1. Nature Medicine 19, 901-908 (2013)

Jones, D.T., et al. Dissecting the genomic complexity underlying medulloblastoma. Nature 488, 100-105 (2012)

Prof. Dr. Christof von Kalle